Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4538-98 continuation pan-tumor study
jRCT2080225345Phase 2Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Aug 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, open-label trial of nivolumab in Nonhematologic neoplasms (2 cohorts), sponsored by Ono Pharmaceutical. Started Aug 2020; status: recruiting.
02
Drugs
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080225345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225345.